ARTICLE | Company News
Organogenesis, Novartis Pharma AG deal
March 27, 2000 8:00 AM UTC
ORG received a $5 million milestone payment from NOVN in advance of obtaining regulatory approval for ORG's Apligraf ( Graftskin) engineered tissue to treat diabetic foot ulcers. ORG submitted a PMA ...